Skip to main content Accessibility help
×
Home
  • Print publication year: 2006
  • Online publication date: December 2009

8 - Adolescents and HIV

Summary

Introduction

HIV-infected adolescents represent an important part of the global AIDS epidemic. In this chapter, the epidemiology of HIV infection in adolescents will be addressed, as well as adolescent development, HIV counseling and testing, and prevention of acquisition of HIV infection by adolescents. Finally, management of HIV-infected adolescents, including reproductive health and gynecologic care, will be addressed. It is not the intent of this chapter to review all aspects of management of HIV-infected adolescents, but rather to address issues that are unique to adolescents. This chapter emphasizes adolescent HIV infection as seen in the USA, but many of the principles are applicable to adolescents in other settings.

Epidemiology

The epidemiology of HIV infection among adolescents in the USA generally mirrors the epidemiology of HIV infection among adolescents in other resource-rich countries. In resource-poor countries, the epidemiology of HIV infection among adolescents is somewhat different in that HIV infection disproportionately affects young women, who generally become infected through heterosexual contact, often with older men.

By the end of 2001, the Centers for Disease Control and Prevention (CDC) estimated that adolescents aged 13 to 19 years made up less than 1% (4428 cases), and young adults aged 20–24 years represented 3.5% (28 665 cases), of all reported individuals with AIDS in the USA [1]. It is estimated that over 100 000 adolescents are living with HIV in the USA, although most are unaware of their infection [2].

Related content

Powered by UNSILO
REFERENCES
Centers for Disease Control and Prevention. human immunodeficiency virus/acquired immune deficiency syndrome Surveillance Report 2001; 13(2): 1–44.
Rotheram-Boris, M. J., Futterman, D.Promoting early detection of human immunodeficiency virus infection among adolescents. Arch. Pediatr. Adolesc. Med. 2000; 154;435–439.
Rosenberg, P. R., Biggar, R. J., Goedert, J. J.Declining age at human immunodeficiency virus infection in the United States. N. Engl. J. Med. 1994;330:789.
Valleroy, L. A., Mackellar, D. A., Karon, J. M.et al.human immunodeficiency virus prevalence and associated risks in young men who have sex with men. J. Am. Med. Assoc. 2000;284: 198–204.
Sweeney, P., Lindegren, M. L., Buehler, J. W., Onorato, I. M., Janssen, R. S.Teenagers at risk of human immunodeficiency virus type I infection. Arch. Pediatr. Adolesc. Med. 1995;149:521–528.
Slap, G. B.Normal physiological and psychosocial growth in the adolescent. J. Adolesc. Hlth Care 1986;7:13S–23S.
Centers for Disease Control and Prevention. Centers for Disease Control and PreventionSurveillance Summaries 2002;51(SS04):1–64.
Wilson, C. M., House, J., Partlow, C.et al.The reaching for excellence in adolescent care and health (Reaching for Excellence in Adolescent Care and Health) Project: study design, methods, and population profile. J. Adolesc. Hlth 2001;29(3S):8–18.
Troiden, R. R.Homosexual identity development. J. Adolesc. Hlth Care 1988;9:105–113.
D'Angelo, L. J., Getson, P. R., Luban, N. L. C., Gayle, H. D.Human immunodeficiency virus infection in urban adolescents: can we predict who is at risk?Pediatrics 1991;88:982–986.
Lindsay, M. K., Johnson, N., Peterson, H. B., Willis, S., Williams, H., Klein, L.Human immunodeficiency virus infection among inner-city adolescent parturients undergoing routine voluntary screening, July 1987 to March 1991. Am. J. Obstet. Gynecol. 1992;167(4):1096–1099.
Futterman, D. C., Peralta, L., Rudy, B. J.et al.The ACCESS (Adolescents Connected to Care, Evaluation, and Special Services) Project: social marketing to promote human immunodeficiency virus testing to adolescents, methods and first year results from a six city campaign. J. Adolesc. Hlth 2001; 29(3S):19–29.
Kaiser Family Foundation. National Survey of Teens on human immunodeficiency virus/acquired immune deficiency syndrome. 2000:1–8.
Centers for Disease Control and Prevention. Recommendations for human immunodeficiency virus testing services for in-patients and outpatients in acute care hospital settings. Morb. Mortal. Wkly Rep. 1993;42:1–17.
Centers for Disease Control and Prevention. human immunodeficiency virus testing among populations at risk for human immunodeficiency virus in nine cities: results from the human immunodeficiency virus Testing Survey (HITS) 1995–96. Morbid. Mortal. Wkly Rep. 1998;47: 1086–1091.
Clark, L. R., Ginsburg, K. R.How to talk to your teenage patients. Contemp. Adolesc.Gynecol. 1995–96;1:23–27.
Remafedi, G.Adolescent homosexuality: psychosocial and medical implications. Pediatrics 1987;79:331–337.
Ginsburg, K. R., Winn, R. J., Rudy, B. J., Crawford, J., Zhao, H., Schwarz, D. F.How to reach sexual minority youth in the health care setting: The teens offer guidance. J. Adolesc. Hlth 2002;31:407–416.
Strurdevant, M. S., Belzer, M., Weissman, G.et al.The relationship of unsafe sexual behavior and the characteristics of sexual partners of human immunodeficiency virus infected and human immunodeficiency virus uninfected adolescent females. J. Adolesc. Hlth 2001;29(3S):64–71.
Caprio, Joseph-Di J., Remafedi, G. J.Adolescents with factitious human immunodeficiency virus disease. J. Adolesc. Hlth Care 1997;21:102–106.
Moscicki, A. B., Houser, J., Ma, Y., Murphy, D., Wilson, C. M. Adolescent males and females with human immunodeficiency virus at high risk for anal squamous intraepithelial lesions. ⅫI Int. acquired immune deficiency syndrome Conf. Durban, South Africa, July 9–14, 2000 (abstract number TuOrB305).
D'Angelo, L. J., Abdalian, S. E., Sarr, M., Hoffman, N., Belzer, M., and The Adolescent Medicine human immunodeficiency virus/acquired immune deficiency syndrome Research Network. Disclosure of serostatus by human immunodeficiency virus infected youth: The experience of the reaching for excellence in adolescent care and health Study. J. Adolesc. Hlth, 2001;29(3S)72–79.
Harlan, W. R., Harlan, E. A., Grillo, G. P.Secondary sex characteristics of girls 12 to 17 years of age: The US health examination survey. J. Pediatr. 1980;96(6):1074–1078.
Zacharias, L., Rand, W. M., Wurtman, R. J.A prospective study of sexual development and growth in American girls: the statistics of menarche. Obstet. Gynecol. Survey 1976;31:325.
Sedlmeyer, I. L., Palmert, M. R.Delayed puberty: Analysis of a large case series from an academic center. J. Clin. Endocrinol. Metab. 2002;87(4):1613–1620.
Frisch, R. E., Revelle, R.Menstrual cycles: fatness as a determinant of minimum weight-for-height for their maintenance or onset. Science 1974;185:949.
Albanese, A., Stanhope, R.Investigation of delayed puberty. Clin. Endocrinol. 1995;43:105–110.
Mahoney, C. P.Evaluating the child with short stature. Pediatr. Clin. North Am. 1987;34:825–849.
Oerter, K. E., Uriarte, M. M., Rose, S. R., Barnes, K. M., Cutler, G. B. Jr.Gonadotropin secretory dynamics during puberty in normal girls and boys. J. Clin Endocrinol. Metab. 1990;71(5):1251–1258.
Finkelstein, J. W., Susman, E. J., Chinchilli, V. M.et al.Effects of estrogen or testosterone on self-reported sexual responses and behaviors in hypogonadal adolescents. J. Clin. Endocrinol. Metab. 1998;83(7):2281–2285.
Susman, E. J., Finkelstein, J. W., Chinchilli, V. M.et al.The effect of sex hormone replacement on behavior problems and moods in adolescents with delayed puberty. J. Pediatr. 1998;133(4):521–525.
Palmert, M. R., Malin, H. V., Boepple, P. A.Unsustained or slowly progressive puberty in young girls: initial presentation and long-term follow-up of 20 untreated patients. J. Clin. Endocrinol. Metab. 1999;84:415–423.
Carpenter, S.Pediatric and Adolescent Gynecology. Philadelphia: Lippincott Williams and Wilkins; 2000.
Chirgwin, K. D., Feldman, J., Muneyyirci-Delale, O., Landesman, S., Minkoff, H.Menstrual function in human immunodeficiency virus-infected women without acquired immunedeficiency syndome. Obstet. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 1996;12(5):489–494.
Pletcher, J. R., Slap, G. B.Menstrual disorders. Amenorrhea. Pediatr. Clin. North Am. 1999;46(3):505–518.
Grinspoon, S., Corcoran, C., Miller, K.et al.Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J. Clin. Endocrinol. Metab. 1997;82(5):1332–1337J.
Golden, N. H.A review of the female athlete triad (amenorrhea, osteoporosis and disordered eating). Int. J. Adolesc. Med. Hlth 2002;14(1):9–17.
Block, R. L., Farinpour, R., Schlechte, J. A., Effects of chronic marijuana use on testosterone, luteinizing hormone, follicle stimulating hormone, prolactin and cortisol in men and women. Drug Alcohol Depend. 1991;28(2):121–128.
Efstratiades, M., Panitsa-Faflia, C., Batrinos, M.Vaginal cytology in endocrinopathies. Acta Cytol. 1983;27(4):421–425.
Speroff, L., Glass, R. H., Kase, N. G. Anovulation and the polycystic ovary. In Clinical Gynecology Endocrinology and Infertility. Philadephia: Lippincott Williams and Wilkins; 1999:487–513.
Lobo, R. A., Carmina, E.The importance of diagnosing the polycystic ovary syndrome. Ann. Intern. Med. 2000;132(12):989–993.
Stafford, D. E., Gordon, C. M.Adolescent androgen abnormalities. Curr. Opin. Obstet. Gynecol. 2002 Oct:14(5):445–451.
Balen, A.Pathogenesis of polycystic ovary syndrom – the enigma unravels?Lancet 1999;354(9183):966–967.
McKenna, T. J.Pathogenesis and treatment of polycystic ovary syndrome. N. Engl. J. Med. 1988; 318:558.
Avyad, C. K., Holeuwerger, R., Silva, V. C., Bordallo, M. A., Breitenbach, M. M.Menstrual irregularity in the first postmenarchal years: an early clinical sign of polycystic ovary syndrome in adolescence. Gynecol. Endocrinol. 2001;15(3):170–177.
Carmina, E., Wong, L., Chang, L., Paulson, R. J., Sauer, M. V., Stanczyk, F. Z., Lobo, R. A.Endocrine abnormalities in ovulatory women with polycystic ovaries on ultrasound. Hum. Reprod. 1997;12(5):905–909.
Gordon, C. M.Menstrual disorders in adolescents: excess androgens and the polycystic ovary syndrome. Pediatr. Clin. North Am. 1999; 46:519–543.
Arslanian, S. A., Lewy, V., Danadian, K., Saad, R.Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance. J. Clin. Endocrinol. Metab. 2002;87(4):1555–1559.
Legro, R. S., Detection of insulin resistance and its treatment in adolescents with polycystic ovary syndrome. J. Pediatr. Endocrinol. Metab. 2002 Dec;15 Suppl 5:1367–1378.
Bravender, T., Emans, S. J.Menstrual disorders. Dysfunctional uterine bleeding. Pediatr. Clin. North Am. 1999;46(3):545–553, viii.
Munro, M. G.Dysfunctional uterine bleeding: advances in diagnosis and treatment. Curr. Opin. Obstet. Gynecol. 2001;13(5):475–489.
Munro, M. G.Abnormal uterine bleeding in the reproductive years. Part I – pathogenesis and clinical investigation. J. Am. Assoc. Gynecol. Laparosc. 1999;6(4):393–416.
, Munro M. G.Abnormal uterine bleeding in the reproductive years. Part II – medical management. J. Am. Assoc. Gynecol. Laparosc. 2000;7(1):17–35.
Kilbourn, C. L., Richards, C. S.Abnormal uterine bleeding. Diagnostic considerations, management options. Postgrad. Med. 2001;109(1):137–138, 141–4, 147–150.
Shah, P. N., Smith, J. R., Well, C., Barton, S. E., Kitchen, V. S., Steer, P. J.Menstrual symptoms in women infected by the human immunodeficiency virous. Obstet. Gynecol. 1994;83(3):397–400.
Dealy, M. F.Dysfunctional uterine bleeding in adolescents. Nurse Pract. 1998;23(5): 2–3, 16, 18–20.
Minjarez, D. A., Bradshaw, K. D.Abnormal uterine bleeding in adolescents. Obstet. Gynecol. Clin. North Am. 2000;27(1):63–78.
Speroff, L., Glass, R. H., Kase, N. G. Dysfunctional uterine bleeding. In Clinical Gynecologic Endocrinology and Infertility. Philadephia: Lippincott Wiliams and Wilkins; 1999: 575–593.
, Klein J. R., Litt, I. F.Epidemiology of adolescent dysmenorrhea. Pediatrics 1981. 68(5):661–664.
Harel, Z.A contemporary approach to dysmenorrhea in adolescents. Pediatr. Drugs 2002;4(12):797–805.
Fedele, L., Bianchi, S., Bocciolone, L., Nola, Di G., Parazzini, F.Pain symptoms associated with endometriosis. Obstet. Gynecol. 1992;79(5 (Pt 1)):767–769.
Hornsby, P. P., Wilcox, A. J., Weinberg, C. R.Cigarette smoking and disturbance of menstrual function. Epidemiology 1998;9(2):193–198.
Hendrix, S. L., Alexander, N. J.Primary dysmenorrhea treatment with a desogestrel-containing low-dose oral contraceptive. Contraception 2002;66(6):393–399.
, Chakmakjian Z. H.A critical assessment of therapy for the premenstrual tension syndrome. J. Reprod. Med. 1983;28(8):532–538.
Raja, S. N., Feehan, M., Stanton, W. R., McGee, R.Prevalence and correlates of the premenstrual syndrome in adolescence. J. Am. Acad. Child Adolesc. Psychiatry 1992;31(5):783–789.
Fisher, M., Trieller, K., Napolitano, B.Premenstrual symptoms in adolescents. J. Adolesc. Hlth Care 1989;10(5):369–375.
American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. DSM-IV Text Revision. R. R. Washington, dendritic cells: American Psychiatric Association, 2000.
Steiner, M., Pearlstein, T.Premenstrual dysphoria and the serotonin system: pathophysiology and treatment. J. Clin. Psychiatry 2000;61 Suppl 12:17–21.
Freeman, E. W.Premenstrual syndrome: current perspectives on treatment and etiology. Curr. Opin. Obstet. Gynecol. 1997;9(3):147–153.
Wenning J. Premenstrual syndrome. In McAnarney, E., Kreipe, R., Orr, D., Comerci, G.Textbook of Adolescent Medicine. Philadelphia, PA: W. B. Saunders Company; 1992: 670–671.
Johnson, S. R.Premenstrual syndrome therapy. Clin. Obstet. Gynecol. 1998;41(2):405–421.
Stone, A.Microbicides: a new approach to preventing human immunodeficiency virus and other sexually transmitted infections. Nat. Rev. Drug Discov. 2002;1(12):977–985.
Guest, F. Education and Counseling: Factors influencing education and counseling. In Kowal, D., ed. Contraceptive Technology 17th edn. New York: Ardent Media Inc; 1998: 249–261.
Derman, S., Peralta, L.Postcoital contraception: present and future options. RU486 (Mifepristone)J. Adolesc. Hlth 1995;16:6–11.
Hatcher, R., Trussel, J., Stewart, F. et al. In Kowal, D., ed. Contraceptive Technology 17th edn. New York: Ardent Media Inc; 1998.
Belzer, M., Rogers, A. S., Camarca, M.et al.Contraceptive choices in human immunodeficiency virus-infected and human immunodeficiency virus at-risk adolescent females. J. Adolesc. Hlth 2000;29S: 93–100.
Hatcher, R., Trussel, J., Stewart, F. et al. human immunodeficiency virus/acquired immune deficiency syndrome and Reproductive Health. In Kowal, D., ed. Contraceptive Technology 17th edn. New York: Ardent Media Inc; 1998: 141–178.
Sivin, I., Moo-Yong, A.Recent developments in contraceptive implants at the Population Council. Contraception 2002;65(1):113–119.
Smallwood, G. H., Meador, M. L., Lenihan, J. P., Shangold, G. A., Fisher, A. C., Creasy, G. W.Efficacy and safety of a transdermal contraceptive system. Obstet. Gynecol. 2001;98(5 Pt 1):799–805.
Hatcher, R. A., Guillebaud, J. The pill: combined oral contraceptive. In Kowal, D. ed. Contraceptive Technology, 17th edn. New York: Ardent Media Inc; 1998: 405–466.
Everett, S. A.Warrem, C. W., Santelli, J. S., Kann, L., Collins, J. L., Kolbe, L. J.Use of birth control pills, condoms, and withdrawal among US high school students. J. Adolesc. Hlth 2000;27(2):12–18.
Hatcher, R. A. Depo-Provera, Norplant, and progestin-only pills (minipills). In Kowal, D. ed. Contraceptive Technology 17th edn. New York: Ardent Media Inc; 1998, 467–509.
Audet, M. C., Moreau, M., Koltun, W. D.et al.Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial. J. Am. Med. Assoc. 2001;285(18):2347–2354.
Abrams, L. S., Skee, D., Matarajan, J., Wong, F. A.Pharmacokinetic overview of Ortho Evra/Evra. Fertil. Steril. 2002;77(2 Suppl 2): S3–S12.
Johansson, E., Brache, V., Alvarez, F.et al.Pharmacokinetic study of different dosing regimes of levonorgestrel for emergency contraception in healthy women. Hum. Reprod. 2002;17(6):1472–1476.
Sivin, I., Mishell, D. R. Jr, Victor, A.et al.A multicenter study of levonorgestrel-estradiol contraceptive vaginal rings. II-Subjective and objective measures of effects. An international comparative trial. Contraception 1981;24(4):359–376.
Ahdieh, L.Pregnancy and infection with human immunodeficiency virus. Clin. Obstet. Gynecol. 2001;44(2):154–166.
Levin, L., Henry-Reid, L., Murphy, D. A.et al.Adolescent Medicine human immunodeficiency virus/acquired immune deficiency syndrome Research Network. Incident pregnancy rates in human immunodeficiency virus-infected and human immunodeficiency virus uninfected at-risk-adolescents. J. Adolesc. Hlth 2001;29S:101–108.
Vermund, S. H., Wilson, C. M., Rogers, A. S., Partlow, C., Moscicki, A. B.Sexually transmitted infections among human immunodeficiency virus-infected and human immunodeficiency virus uninfected high-risk youth in the reaching for excellence in adolescent care and health study. J. Adol. Hlth 2001;9S:49–56.
Moscicki, A. B., Ellenberg, J. H., Vermund, S. H.et al.Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus. Arch. Pediatr. Adolesc. Med. 2000;54(2):127–134.
Wasserheit, J. N.Epidemiological synergy. Inter-relationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex. Transm. Dis. 1992;19(2):61–77.
Laga, M., Manoka, A., Kivuvu, M.et al.Non-ulcerative sexually transmitted diseases as risk factors for human immunodeficiency virus transmission in women: results from a cohort studyacquired immune deficiency syndrome 1993;7(1):95–102.
Fleming, D. T., Wasserheit, J. N.From epidemiological synergy to public health policy and practice: The contribution of other sexually transmitted diseases to sexual transmission of human immunodeficiency virus infection. Sex. Transm. Infect. 1999;75(1):3–17.
Pilon, R., Sandstrom, P., Burchell, A. et al. Transmitted human immunodeficiency virus reverse transcriptase inhibitor resistance mutation stability in antiretroviral therapy-naive recent seroconverters: results of the polaris human immunodeficiency virus seroconversion study. ⅪV Int. acquired immune deficiency syndrome Conf.; 2002 July 9; Barcelona. Abstract TuPeB4611.
Robertson, D., McMillan, A., Young, H.Clinical Practice in Sexually Transmissible Diseases. 2nd edn. Edinburgh: Churchill Livingstone; 1989.
Goldenberg, R. L., Andrews, W. W., Yuan, A. C., MacKay, H. T., Louis, M. E.StSexually transmitted diseases and adverse outcomes of pregnancy. Clin. Perinatal. 1997;24(1):23–41.
Korn, A. P.Pelvic inflammatory disease in women infected with human immunodeficiency virus. acquired immune deficiency syndrome Patient Care STDs 1998;12(6):431–434.
, Moscicki A B, , Ma Y, , Holland C, , Vermund S H.Cervical ectopy in adolescent girls with and without human immunodeficiency virus infection. J. Infect. Dis. 2001;183(6):865–870.
Centers for Disease Control and Prevention. Sexually transmitted diseases treatment guidelines 2002. Morbid. Mortal. Wkly Rep. 2002;51(R6):1–78.
Ahmed, S., Lutalo, T., Wawer, M.et al.human immunodeficiency virus incidence and sexually transmitted disease prevalence associated with condom use: a population study in Rakai, Uganda. acquired immune deficiency syndrome 2001;15(16):2171–2179.
Holmes, K., Stamm, W. Lower genital tract infection syndromes in women. In Holmes, K., Sparling, F., Lemon, S.et al. eds. Sexually Transmitted Diseases. 3rd edn. New York: McGraw-Hill; 1999: 766.
Neinstein, L. S. ed. Adolescent Health Care. A Practical Guide. 4th edn. Lippincott Williams and Wilkins, Philadelphia, PA. 2002.
California STD/human immunodeficiency virus Prevention Training Center. Core STD Curriculum: Comprehensive Outlines for Clinical STD Management. 1999.
Ledru, S., Meda, N., Ledru, E., Bazie, A. J., Chiron, J. P.human immunodeficiency virus-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 1997;350(9086):1251–1252.
Jamieson, D. J., Duerr, A., Klein, R. S.et al.Longitudinal analysis of bacterial vaginosis: findings from the human immunodeficiency virus epidemiology research study. Obstet. Gynecol. 2001;98(4):656–663.
Hillier, S., Holmes, K. K. Bacterial vaginosis. In Holmes, K., Sparling, F., Lemon, S.et al. Sexually Transmitted Diseases. 3rd edn. New York: McGraw-Hill; 1999: 563–586.
Amsel, R., Totten, P. A., Spiegel, C. A., Chen, K. C., Eschenbach, D., Holmes, K. K. Nonspecific vaginitis: diagnostic criteria and microbial and epidemiologic associations. In Holmes, K., Sparling, F., Lemon, S.et al. eds. Sexually Transmitted Diseases. 3rd edn. New York: NcGraw-Hill; 1999: 569.
Schwebke, J. R.Asymptomatic bacterial vaginosis: response to therapy. Am. J. Obstet. Gynecol. 2000;183(6):1434–1439.
Hay, P. Sr.National guideline for the management of bacterial vaginosis. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). Sex. Transm. Infect. 1999;75 (Suppl 1):S16–S18.
Sobel, J. D. Vulvovaginal candidiasis. In Holmes, K., Sparling, F., Lemon, S.et al. eds. Sexually Transmitted Diseases. 3rd edn., New York: McGraw-Hill;1999:629–639.
Sobel, J. D., Ohmit, S. E., Schuman, P.et al.The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from human immunodeficiency virus (human immunodeficiency virus)-seropositive and at-risk human immunodeficiency virus-seronegative women. J. Infect. Dis. 2000;183(2):286–293.
Sobel, J. D.Treatment of vaginal Candida infections. Expert Opin. Pharmacother. 2002;3(8):1059–1065.
Sobel, J. D., Kapernick, P. S., Zervos, M.et al.Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. Am. J. Obstet. Gynecol. 2001;185(2):363–369.
Jackson, D. J., Rakwar, J. P., Bwayo, J. J., Kreiss, J. K., Moses, S.Urethal Trichomonas vaginalis infection and human immunodeficiency virus transmission. Lancet 1997;350(9084):1076.
Krieger, J., Alderete, J. Trichomonas vaginalis and trichomoniasis. In Holmes, K., Sparling, F., Lemon, S.et al.Sexually Transmitted Diseases. 3rd edn, New York: McGraw-Hill; 1999:587–604.
Moodley, P., Wilkinson, D., Connolly, C., Moodley, J., Sturm, A. W.Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus. Clin. Infect. Dis. 2002;34(4):519–22.
Damme, L., Ramjee, G., Alary, M.et al.COL-1492 study group. Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on human immunodeficiency virus transmission in female sex workers: a randomized controlled trial. Lancet 2002; 360(9338):971–977.
Igra, V.Pelvic inflammatory disease in adolescents. acquired immune deficiency syndrome Patient Care STDs 1998;12(2):109–124.
Westrom, L., Eschenbach, D. Pelvic inflammatory disease. In Holmes, K., Sparling, F., Lemon, S.Sexually Transmitted Diseases. 3rd edn, New York: McGraw-Hill; 1999: 783–809.
HRP Annual Technical Report 1995: Executive Summary. Available at: www.who.int/reproductive-health/publications/HRP-ATRs/1995/execsum.html. Acessed November 11, 2005.
Irwin, K. L., Moorman, A. C., O'Sullivan, M. J.et al.Influence of human immunodeficiency virus infection on pelvic inflammatory disease. Obstet. Gynecol. 2000;95(4):525–534.
Bersoff-Matcha, S. J., Horgan, M. M., Fraser, V. J., Mundy, L. M., Stoner, B. P.Sexually transmitted disease acquisition among women infected with human immunodeficiency virus type 1. J. Infect. Dis. 1998; 78(4): 1174–1177.
Irwin, K. L., Moorman, A. C., O'Sullivan, M. J.et al.Influence of human immunodeficiency virus infection on pelvic inflammatory disease. Obstet. Gynecol. 2000;95(4):525–534.
Cohen, C. R., Sinej, S., Reilly, M.et al.Effect of human immunodeficiency virus type 1 infection upon acute salpingitis: a laparoscopic study. J. Infect. Dis. 1998;178(5):1352–1358.
Rice, P. A., Schachter, J.Pathogenesis of pelvic inflammaotory disease: what are the questions?J. Am. Med. Assoc. 1991;266(18): 2587–2593.
Slap, G. B., Forke, C. M., Cnaan, A.et al.Recognition of tubo-ovarian abscess in adolescents with pelvic inflammatory disease. J. Adolesc. Hlth. 1996;18(6):397–403.
Walker, C. K., Workowski, K. A., Washington, A. E., Soper, D., Sweet, R. L.Anaerobes in pelvic inflammatory disease: implications for the Centers for Disease Control and Prevention's guidelines for treatment of sexually transmitted diseases. Clin. Infect. Dis. 1999;28(Suppl 1):S29–S36.
Jacobson, D., Mizell, S., Peralta, L.et al.Concordance of human papilloma virus in the cervix and urine of adolescents with a high prevalence of human papillomavirus. Pediatr. Infect. Dis. J. 2000;19(8):722–728.
Minkoff, H., Feldman, J., DeHovitz, J., Landesman, S., Burk, R.A longitudinal study of human papillomavirus carriage in human immunodeficiency virus-infected and human immunodeficiency virus-uninfected women. Am. J. Obstet. Gynecol. 1998;178(5):982–986.
Palefsky, J. M., Minkoff, H., Kalish, L. A.et al.Cervicovaginal human papillomavirus infection in human immunodeficiency virus-1 (human immunodeficiency virus)-positive and high-risk human immunodeficiency virus-negative women. J. Natl Cancer Inst. 1999;337(3):22–236.
Sun, X. W., Kuhn, L., Ellerbrock, T. V., Chiasson, M. A., Bush, T. J., Wright, T. C.Human papillomavirus infection in women infected with the human immunodeficiency virus. N. Engl. J. Med. 1997;337(19):1343–1349.
Jamieson, D. J., Duerr, A., Burk, R.et al.Characterization of genital human papillomavirus infection in women who have or who are at risk of having the human immunodeficiency virus infection. Am. J. Obstet. Gynecol. 2002;186(1):21–27.
Ahdieh, L., Munoz, A., Vlahov, D., Trimble, C., Timpson, L., Shah, K.Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. Am. J. Epidemiol. 2000;151(12):1148–1157.
Brown, D. R., Bryan, J. T., Cramer, H., Katz, B. P., Handy, V., Fife, K. H.Detection of multiple human papillomavirus types in condylomata acuminata from immunosuppressed patients. J. Infect. Dis. 1994;70:759–765.
Uberti-Foppa, C., Origoni, M., Maillard, M.et al.Evaluation of the detection of human papillomavirus genotypes in cervical specimens by hybrid capture as screening for precancerous lesions in human immunodeficiency virus-infected women. J. Med. Virol. 1998;56:133–137.
Garzetti, G. G., Ciavattini, A., Butini, L., Vecchi, A., Montroni, M. Cervical dysplasia in human immunodeficiency virus-seropositive women: role of human papillomavirus infection and immune status. Gynecol. Obstet. Invest. 1995;40(1):52–56.
Massad, L. S., Riester, K. A., Anastos, K. M.et al.Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with human immunodeficiency virus. Women's Interagency human immunodeficiency virus Study Group. J. Acquir. Immune Defic. Syndr. 1999;21(1):33–41.
Delmas, M. C., Larsen, C., Benthem, B.et al.Cervical squamous intraepithelial lesions in human immunodeficiency virus-infected women: prevalence, incidence, and regression. acquired immune deficiency syndrome 2000;14(12):1775–1784.
Kiviat, N., Kovtsky, L. A., Paavonen, J. Cervical neoplasia and other STD related genital tract neoplasias. In Holmes, K., Sparling, F., Lemon, S.et al. eds. Sexually Transmitted Diseases. 3rd edn. New York: McGraw-Hill; 1999: 811–831.
Chiasson, M. A., Declining acquired immune deficiency syndrome mortality in New York City. New York City Department of Health. Bull. N Y Acad. Med. 1997;74(1):151–152.
Weber, T., Chin, K., Sidhu, J. S., Janssen, R. S. Prevalence of invasive cervical cancer among human immunodeficiency virus-infected and uninfected hospital patients, 1994–1995. Program Abstracts of 5th Conf. Retroviruses Opportunistic Infect. (Chicago, interleukin; 1998). Abstract 717.
Phelps, R., Smith, D. K., Gardner, L. et al. Incidence of lung and invasive cervical cancer in human immunodeficiency virus-infected women. Program Abstracts 13th Int. Conf. acquired immune deficiency syndrome (Durban, South Africa; July 9–14, 2000). Abstract number TuPeB3168.
Lomalisa, P., Smith, T., Guidozzi, F.Human immunodeficiency virus infection and invasive cervical cancer in South Africa. Gynecol. Oncol. 2000;77(3):460–463.
Maiman, M., Fruchter, R. C., Serur, E., Remy, J. C., Feurer, G., Boyce, J.Human immunodeficiency virus infection and cervical neoplasia. Gynecol. Oncol. 1990;38(3):377–382.
Klevens, R. M., Fleming, P. L., Mays, M. A., Frey, R. Characteristics of women with acquired immune deficiency syndrome and invasive cancer. Obstet Gynecol. 1996;88(2):269–273.
Solomon, D., Darvey, D., Kurman, R.et al.The 2001 Bethesda System: terminology for reporting results of cervical cytology. J. Am. Med. Assoc. 2002;287(16):2114–2119.
American College of Obstetricians and Gynecologists. Cervical cytology: evaluation and management of abnormalities (Technical Bulletin No. 183). Practice Guidelines August 1993.
Wright, T. C., Moscarelli, R. D., Dole, P., Ellerbrock, T. V., Chiasson, M. A., Vandevanter, N.Significance of mild cytologic atypia in women infected with human immunodeficiency virus. Obstet. Gynecol. 1996;87(4):515–519.
Holcomb, K., Abulafia, O., Matthews, R. P.et al.significance of atypical squamous cells of undetermined significance sytology in human immunodeficiency virus-infected women. Gynecol. Oncol. 1999;75(1):118–121.
Duska, L. R., Flynn, C. F., Chen, A., Whall-Strojwas, D., Goodman, A.Clinical evaluation of atypical glandular cells of undetermined significance on cervical cytology. Obstet. Gynecol. 1998;91(2):278–282.
Kennedy, A. W., Salmieri, S. S., Wirth, S. L., Biscotti, C. V., Tuason, L. J., Travarca, M. J.Results of the clinical evaluation of atypical glandular cells of undetermined significance (atypical glandular cells of undetermined significance) detected on cervical cytology screening. Gynecol. Oncol. 1998;63(1):14–18.
Korn, A. P., Judson, P. L., Zaloudek, C. J.Importance of atypical glandular cells of uncertain significance in cervical cytologic smears. J. Reprod. Med. 1998;43(9):774–778.
Fruchter, R., Maiman, M., Sedlis, A., Bartley, L., Camilien, L., Arrastia, C. D.Multiple recurrences of cervical intraepithelial neoplasia in women with the human immunodeficiency virus. Obstet. Gynecol. 1996;87(3):338–344.
Holcomb, K., Matthews, R. P., Chapman, J. E.et al.The efficacy of cervical colonization in treatment of cervical intraepithelial neoplasia in human immunodeficiency virus-infected women. Gynecol. Oncol. 1999;74(3):428–431.
Maiman, M., Watts, D. H., Andersen, J., Clax, P., Merino, M., Kendall, M. A.Vaginal 5-fluorouracil for high-grade cervical dysplasia in human immunodeficiency virus infection: a randomized trial. Obstet. Gynecol. 1999;94(6):954–961.
Fleming, D. T., McQuillan, G. M., Johnson, R. E.et al.Herpes simplex virus type 2 in the United States, 1976 to 1994. N. Engl. J. Med. 1997;337(16):1105–1111.
Augenbraun, M., Feldman, J., Chirgwin, K.et al.Increased genital shedding of herpes simplex virus type 2 in human immunodeficiency virus-seropositive women. Ann. Int. Med. 1995;123(11):845–847.
Mostad, S. B., Kreiss, J. K., Ryncarz, A. J.et al.Cervical shedding of herpes simplex virus in human immunodeficiency virus-infected women: effects of hormonal contraception, pregnancy and vitamin A deficiency. J. Infect. Dis. 2000;181(1):58–63.
Retesm, M., Graber, J., Reeves, W. Acyclovir-resistant herpes simplex virus: preliminary results from a national surveillance system. Program and Abstracts of the Int. Conf. Emerging Infect. Dis. 1998 Mar 10; Atlanta, GA (Abstract 55).
Tapert, S. F., Aarons, G. A., Sedlar, G. R., Brown, S. A.Adolescent substance use and sexual risk-taking behavior. J. Adolesc. Hlth. 2001;28(3):181–189.
Nyrphy, D. A., Durako, S. D., Moscicki, A. B.et al. and the Adolescent Medicine human immunodeficiency virus/acquired immune deficiency syndrome Research Network. No change in health risk behaviors over time among human immunodeficiency virus-infected adolescents in care: role of psychological distress. J. Adolesc. Hlth 2001;29S:57–63.
Boyer, C. B., Shafer, M., Wibbelsman, C. J., Seeberg, D., Teitle, E., Lovell, N.Associations of sociodemographic psychosocial and behavioral factors with sexual risk and sexually transmitted diseases in teen clinic patients. J. Adolesc. Hlth 2000;27(2):102–111.
, Sanders-Phillips K.Factors influencing human immunodeficiency virus/acquired immune deficiency syndrome in women of color. Public. Hlth Rep. 2002;117 Suppl 1:S151–S156.